Table 2 Results of the serological tests and sero-neutralization test in hemodialysis patients. Results are expressed as number (% of samples tested).

From: Presence of specific SARS-COV2 antibodies in hemodialysis patients and their caregivers after the first wave of COVID-19

 

M0

N = 451

M3

N = 414

M6

N = 382

Rapid serological test

BIOSYNEX+ 

38 (8.4)

28 (6.8)

52 (13.8)

BIOSYNEX −

413 (91.6)

383 (93.2)

324 (86.2)

Missing data

0

3

7

Main laboratory tests

Anti-S ELISA + 

43 (9.6)

32 (7.9)

62 (16.8)

Anti-S ELISA −

405 (90.4)

375 (92.1)

307 (83.2)

Missing data

3

7

13

Sero-neutralization + 

26 (5.8)

27 (6.6)

59 (16.0)

Sero-neutralization –

422 (94.2)

380 (93.4)

310 (84.0)

Missing data

3

7

13

Immunization status

Anti-SARS-COV2 neutralizing antibodies

26 (5.8)

27 (6.6)

59 (16.0)

Anti-SARS-COV2 non-neutralizing antibodies

17 (3.8)

5 (1.2)

3 (0.8)

Absence of anti-SARS-COV2 antibodies

405 (90.4)

375 (92.2)

307 (83.2)

Missing data

3

7

13

Additional laboratory tests

Anti-RBD ELISA + 

37 (8.3)

32 (7.9)

51 (14.2)

Anti-RBD ELISA –

408 (91.7)

373 (92.1)

308 (85.8)

Missing data

6

9

23

  1. Values with significant differences between M6 and M0 or M3 are in bold.
  2. The number of missing data is specified (given in italics).